Research on the Impact of Epidemic Control on Airlines—Taking Chinese and American Aviation Industries as Examples
- DOI
- 10.2991/aebmr.k.220307.178How to use a DOI?
- Keywords
- Epidemic; Government control; Airlines; Auxiliary revenue
- Abstract
After the outbreak in 2019, the novel coronavirus ravaged the world in less than half a year. The novel coronavirus not only causes inconvenience to people’s lives and travels, but also greatly hinders the development of the world economy and even leads to some extent to an anti-globalization trend. Many countries have regulated the transportation and tourism industries, especially the aviation industry. Based on this background, this paper takes China Airlines Company and American Airlines Company as examples and compares these two companies to analyze the impact of the epidemic development on government control, then analyzes the government control on aerospace profits and stocks while at the same time using Travel Daily data to reduce company losses through such measures as relaxing flight control, strengthening enterprise management, and increasing auxiliary business. The author concludes from the data that novel coronaviruses will coexist with humans for a long time, while small and medium-sized space enterprises will exit the market because they are not adequately funded to withstand the impact of the outbreak, and large civil aviation will enter an oligopoly because there are fewer companies competing with them for the market.
- Copyright
- © 2022 The Authors. Published by Atlantis Press International B.V.
- Open Access
- This is an open access article under the CC BY-NC license.
Cite this article
TY - CONF AU - Yue Yang PY - 2022 DA - 2022/03/26 TI - Research on the Impact of Epidemic Control on Airlines—Taking Chinese and American Aviation Industries as Examples BT - Proceedings of the 2022 7th International Conference on Financial Innovation and Economic Development (ICFIED 2022) PB - Atlantis Press SP - 1081 EP - 1085 SN - 2352-5428 UR - https://doi.org/10.2991/aebmr.k.220307.178 DO - 10.2991/aebmr.k.220307.178 ID - Yang2022 ER -